Karyopharm Therapeutics Q2 2022 Earnings Preview

• Karyopharm Therapeutics (NASDAQ:KPTI) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open.
• The consensus EPS Estimate is -$0.64 (+9.9% Y/Y) and the consensus Revenue Estimate is $35.96M (+59.1% Y/Y).
• Over the last 3 months, EPS estimates have seen 4 upward revisions and 4 downward. Revenue estimates have seen 2 upward revisions and 4 downward.